Bleeding oesophageal varices
Keywords:
Portal Hypertension, oesophageal varices, liver cirrhosisAbstract
Upper gastrointestinal bleeding, is serious complication of portal hypertension,
associated with high mortality. Several factors are associated with prognosis and
treatment, such as hepatocelular function expressed by Child-Pugh classification.
The authors review several aspects of phisiopathology and farmacology. Also review
different surgical aproach to bleeding patient, including livrer transplatation.
Downloads
References
Bosch J, Navasa M, Garcia-Pagán JC et al. Portal hypertension. Med Clin North Am 1989; 73: 931-953.
Pagliaro L, D' Amico G, Pasta L, et al: Portal hypertension in cirrhosis: Natural history. In: Bosch, J., Grozmann, R.J. (Eds). Portal hypertension. Pathophysiology and treatment. Blackwell, Oxford 1994; 72-92.
Lebrec D, DeFleury P, Rueff B, et al: Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139-1144.
Viallet A, Marleau D, Huet M, et al: Hemodynamic evaluation of patients with intrahepatic portal hypertension: relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975; 69: 1297-1300.
North Italian Endoscopic Club for the study and Treatment of esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319:1401-1407.
Bosch J, García-Pagán JC: Hipertension Portal. In: Rodés J, Valenzuela J, editores. Gastroenterologia y Hepatologia 2. Santiago-Chile: Mediterraneo, 1997; 652.
Burroughts AK, McCormik PA. Natural history and prognosis of variceal bleeding. Bailliere' s Clinical Gastroenterology 1992;6:437-450.
Schlichting P, Christensen E, Faurholdt L et al. Main causes of death in cirrhosis. Scan J Gastroenterol 1983; 18: 881-888.
Rodés J, Chantar C. Editores. Actualidades en Gastroenterología y Hepatologia.Barcelona : Prous,1996.
Bosch J, Terés J. Immediate management of variceal hemorrhage. Pharmacological measures and balloon tamponade. Gastrointest Endosc Clin North Am 1992; 2: 43-58.
Bosch J, Bruix J, Mas A et al. Rolling review: the treatment of major complications of cirrhosis. Aliment Pharmacol Ther 1994; 8: 639-657.
McCormik PA, Jenkins SA, McIntyre N, et al. Why portal hypertensive varices bled: A hypothesis. Gut 1995; 36: 100-103.
Panés J, Casadevall M, Piqué J et al. Effects of acute normovolemia on gastric mucosal blood flow in rats: Role of nitric oxide. Gastroenterology 1992;103: 407-413.
Feu F, D'Amico G, Bosch J. The acute bleeding episode: Advances in drug therapy. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson 1995; 9-22.
Rimola A. Infecciones bacterianas en la enfermedad hepática. In: Rodés J,Benhamou JP, Bircher J et al, editors. Tratado de hepatologia clínica. Barcelona:Masson-Salvat Medicina, 1993; 1503-1515.
Soriano C, Guarner C, Tomás A et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-1272.
Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascitis Club. J Hepatol 2000;32:142-153.
Burroughs AK, Bosch J. Manifestaciones clínicas y tratamiento de los episódios hemorrágicos en los pacientes cirróticos. In: Rodés J, Benhamou JP et al editors. Tratado de hepatologia clínica. Barcelona: Masson-Salvat Medicina 1993; 481-502.
Grozmann RJ, Kravetz D, Bosch J et al. Nitroglycerine improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982; 2:757-762.
Soderlund C, Magnusson L, Torngren S et al. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990; 25:622-639.
Bosch J, Kravetz D, Rodés J. Effects of somatostatin on hepatic and systemichemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981; 80:518-525.
McKee R: A study of octreotide in oesophageal varices. Digestion 1990; 45: 60-65.
Primignani M, Nolte A, Vazzoler MC et al. The effect of octreotide on intraoesophageal variceal pressure in liver cirrhosis is unpredictable. Hepatology 1990; 12: 989.
Escorsell A, Bandi JC, François E et al. Desensitation of the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Hepatology 1996; 24: 207.
Burroughs AK, Patch D. Drug therapy: Comparison with other therapies for portal hypertension. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson 1995; 44-49.
Groszmann R, de Franchis R. Portal Hypertension. In: Schiff E, Sorrell M, Maddrey W, eds. Diseases of the liver. Philadelphia: Lippincott-Raven 1999:419.
Haddock G, Garden O, Mckee R, et al. Esophageal tamponade in the management of acute variceal hemorrage. Dig Dis Sci 1989;24:913.
Brewer TG: Treatment of acute gastroesophageal variceal hemorrhage. Med Clin North Am 1993; 77: 993.
Graham DY, Smith JL. The course of patients after variceal hemorrhage.Gastroenterology 1981;80:800.
De Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390-394.
D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A metaanalytic review. Hepatology 1995; 22:332.
Gostout GJ, Wang KK, Alquist DA et al. Acute bleeding: Experience of a specialized management team. J Clin Gastroenterolol 1992; 14:260.
Jensen DM, Kovacs TO, Randall GM et al. Initial results of a randomized study of emergency banding vs. sclerotherapy for bleeding gastric or esophageal varices[abstract]. Gastrointest Endosc 1993; 39:279.
Laine L, El-Newihi HE, Migikovsky B et al. Endoscopic ligation compared with sclerotherapy for treatment of bleeding esophageal varices. Ann Intern Med 1993; 119:1.
Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analyis. Ann Intern Med 1995;123:280.
Eck N. Citado por Child C.G. Eck's fistula. Surg Gynecol Obstet 1953;96:375.
Hahn M, Massen M, Nencki M, Pavlov J. Die Eck sche fistel zwischen der unteren hohlvene und der pfotadund ihre folgen fur den organismus. Arch Exper Pathol Pharmolol 1893;32:162-210.
Whipple A. The problem of portal hypertension in relation to hepatoesplenopathies. Ann Surg 1945;122:449-475.
Warren W, Zeppa R, JJ F. Selective transplenic descompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-455
Starzl TE, Demetrius AS, Van Thiel D. Liver transplantation (1). New Engl J Med 1989;321:1014-1022.
Grace N, Conn H, Resnick YC. Distal splenorenal versus portal systemic shunts after haemorrhage from varices: a randomized controlled trial. Hepatology1988;8:1475.
Starzl T, Francavilla A, Halgrimson C. The origin, hormonol nature and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet1973;137:179.
Conn H. Therapeutic portocaval anastomosis: to shunt or not to shunt.Gastroenterology 1974;67:1065.
Resnick R, Iber F, Ishihara A. A controlled study of the therapeutic portocaval shunt. Gastroenterology 1974;67:843.
Rueff B, Prandi D, Degos F. A controlled study of therapeutic portocaval shunt in alcoholic cirrhosis. Lancet 1976;1:655.
Henderson J, Warren W, Millikan W. Distal splenorenal shunt with splenopancreatic disconection. A 4-year assessment. Ann Surg 1989;210:332-341.
Rikkers L, Sorrel T, Gongliang J. Which portosystemic shunt is best? Gastroenterol Clin North Am 1992;21:179.
Millikan W, Warren W, Henderson J. The Emory prospective randomized trial:selective versus nonselective shunt to control variceal bleeding. Ten- year follow-up. Ann Surg 1985;201:712-722.
Da Silva L, Strauss E, Gayotto L. A randomized trial for elective surgical treatment of portal hypertension in mansioma squistosomiasis. Ann Surg 1986;204:148.
Spina G, Henderson J, Rikkers L. Distal splenorenal shunt versus endoscopic sclerotherapy in prevention of variceal rebleeding: a meta-analysis of randomized clinical trials. J Hepatol 1992;16:338.
Pera C, Visa J. La anastomosis esplenorrenal selectiva modificada para la via posterior retroperitoneal. Técnica y primeros resultados. Rev Quir Esp 1977;4:81-89.
Lacy A, Navasa M, Gilabert R. Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow. Hepatology 1992;15:616.
Maillard J, Flamant Y, Hay J, Chandler J. Selectivity of the distal splenorenal shunt. Surgery 1979;86:663-671.
Widrich W, Robbins A, Johnson W. Long-term follow-up of distal splenorenal shunts:evaluation by arterigraphy, shuntography, transhepatic portal venography and cinefluorography. Radiology 1980; 134:341-345.
Stipa S, Ziparo V, Fabrini G, Lupino R. A randomized controlled trial of mesentericocaval shunt with autologous jugular vein. Surg Gynecol Obstet 1981;153:353.
Sarfeh I, Eb R, Fardi M et al. Clinical implications of portal hemodynamics after small-diameter portocaval H graft. Surgery 1984;96:223.
Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardivasc Surg 1973;66(5):677-685.
Starzl T, Marchioro T, Von Kaulla K, Hermann G, Brittain R, Waddell W.Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659.
Henderson J, Gilmore G, Hooks M. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992;216:248.
Ringe B, Lang H, Tusch G, Pichlmayr R. Role of liver transplantation in management of esophageal variceal haemorrhage. World J Surg 1994;18:233-239.
Shiffman ML, Jeffers L, Hoofnagle JH et al. The role of TIPS for the treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995; 22:1591.
Cello JP, Grendell JH, Crass RA et al. Endoscopic sclerotherapy versus portocaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med 1984; 311: 1589.
Warren WD, Millikan WJ, Henderson JM et al. Ten years of portal hypertensive surgery at Emory: Results and new perspectives. Ann Surg 1982; 195: 530.
Freedman AM, Sanyal AJ, Tisnado J et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics 1993; 13: 1185.
Haskal ZL, Pentecost MJ, Rubin RA. Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: Report of two cases. Radiology 1993, 188: 85.
Azoulay D, Castaing D, Dennison A et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: Preliminary report of a prospective study. Hepatoloy 1994; 19:129.
Rodriguez-Laiz JM, Banares R, Echenagusia A et al. Effects of transjugular intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics and hepatic function in patients with portal hypertension: Preliminary results. Dig Dis Sci 1995; 40:2121.
Van der Linden P, Le Moine O, Ghysels M et al. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: Effects on right ventricular function. Hepatology 1996; 23:982.
Freedman AM, Sanyal AJ, Tisnado J et al. Results with percutaneous transjugular intrahepatic portosystemic stent-shunts for control of variceal hemorrhage in patients awaiting liver transplantation. Transplant Proc 1993; 25: 1087.
Rossle M, Haag K, Ochs A et al. The transjugular intrahepatic portosystemic stentshunt procedures for variceal bleeding. N Engl J Med 1994;330:165.
Sanyal AJ, Freedman AM, Shiffman ML et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology 1994; 20:46.
Riggio O, Merli M, Pedretti G et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: Incidence and risk factors. Dig Dis Sci 1996; 41:578
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
